ID   IBEP-2
AC   CVCL_0340
SY   IBEP2
DR   MCCL; MCC:0000236
DR   Wikidata; Q54897170
RX   PubMed=9610725;
RX   PubMed=15218360;
RX   PubMed=16142302;
CC   Doubling time: 29 hours (PubMed=9610725).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
RX   PubMed=9610725; DOI=10.1002/(SICI)1097-0215(19980529)76:5<677::AID-IJC11>3.0.CO;2-1;
RA   Siwek B., Larsimont D., Lacroix M., Body J.-J.;
RT   "Establishment and characterization of three new breast-cancer cell
RT   lines.";
RL   Int. J. Cancer 76:677-683(1998).
//
RX   PubMed=15218360; DOI=10.1023/B:BREA.0000032922.87541.31;
RA   Journe F., Body J.-J., Leclercq G., Nonclercq D., Laurent G.;
RT   "Estrogen responsiveness of IBEP-2, a new human cell line derived from
RT   breast carcinoma.";
RL   Breast Cancer Res. Treat. 86:39-53(2004).
//
RX   PubMed=16142302; DOI=10.3892/ijo.27.4.881;
RA   de Longueville F., Lacroix M., Barbuto A.-M., Bertholet V., Gallo D.,
RA   Larsimont D., Marcq L., Zammatteo N., Boffe S., Leclercq G.,
RA   Remacle J.;
RT   "Molecular characterization of breast cancer cell lines by a
RT   low-density microarray.";
RL   Int. J. Oncol. 27:881-892(2005).
//